MX9101574A - Nuevas azetidinonas substituidas como agentes anti-inflamatorios y antidegenerativos - Google Patents
Nuevas azetidinonas substituidas como agentes anti-inflamatorios y antidegenerativosInfo
- Publication number
- MX9101574A MX9101574A MX919101574A MX9101574A MX9101574A MX 9101574 A MX9101574 A MX 9101574A MX 919101574 A MX919101574 A MX 919101574A MX 9101574 A MX9101574 A MX 9101574A MX 9101574 A MX9101574 A MX 9101574A
- Authority
- MX
- Mexico
- Prior art keywords
- inflammatory
- new
- degenerative agents
- azetidinones
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59761790A | 1990-10-15 | 1990-10-15 | |
US07/761,191 US5229381A (en) | 1983-12-01 | 1991-09-20 | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9101574A true MX9101574A (es) | 1992-06-05 |
Family
ID=27082866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX919101574A MX9101574A (es) | 1990-10-15 | 1991-10-14 | Nuevas azetidinonas substituidas como agentes anti-inflamatorios y antidegenerativos |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0481671A1 (es) |
JP (1) | JPH05132458A (es) |
AU (1) | AU648345B2 (es) |
CA (1) | CA2052973A1 (es) |
FI (1) | FI914833A (es) |
IE (1) | IE913612A1 (es) |
IL (1) | IL99658A0 (es) |
MX (1) | MX9101574A (es) |
NO (1) | NO914027L (es) |
PT (1) | PT99226A (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9103654D0 (en) * | 1991-02-21 | 1991-04-10 | Merck Sharp & Dohme | Chemical process |
WO1993000332A1 (en) | 1991-06-25 | 1993-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
US5688785A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
EP0524595A1 (en) * | 1991-07-23 | 1993-01-27 | Schering Corporation | Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
US5149838A (en) * | 1991-09-20 | 1992-09-22 | Merck & Co., Inc. | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents |
GB2266527A (en) * | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted azetidinones useful in the treatment of leukemia |
WO1994010143A1 (en) * | 1992-10-27 | 1994-05-11 | Merck & Co., Inc. | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
MY128261A (en) * | 1992-10-27 | 2007-01-31 | Merck Sharp & Dohme | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
US5591737A (en) * | 1992-12-17 | 1997-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
CA2120221A1 (en) * | 1993-04-23 | 1994-10-24 | Allan W. Rey | N-substituted 2-azetidinones |
GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
JPH09510212A (ja) * | 1994-03-11 | 1997-10-14 | メルク エンド カンパニー インコーポレーテッド | 肺疾患を処置するための組成物 |
CN1175246A (zh) * | 1994-12-22 | 1998-03-04 | 史密丝克莱恩比彻姆有限公司 | 用于治疗动脉粥样硬化的取代的氮杂环丁-2-酮 |
AU5014496A (en) * | 1995-03-23 | 1996-10-08 | Japan Tobacco Inc. | Diphenylmethyl-azetidinone compounds and elastase inhibitor |
US5747485A (en) * | 1995-04-13 | 1998-05-05 | Merck & Co., Inc. | Substituted azetidiones as anti-inflammatory and antidegenerative agents |
HUP9901153A3 (en) * | 1995-07-01 | 1999-11-29 | Smithkline Beecham Plc | Azetidinone derivatives for the treatment of atherosclerosis, their production and pharmaceutical compositions containing them |
WO1997013750A1 (en) * | 1995-10-09 | 1997-04-17 | Chiroscience Limited | Azetidinones and their therapeutic use as cytokine inhibitors |
EP0869943A1 (en) * | 1995-12-08 | 1998-10-14 | Smithkline Beecham Plc | Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
EE9800299A (et) * | 1996-03-22 | 1999-06-15 | The Du Pont Merck Pharmaceutical Company | R-a-propüül-piperonüülamiini ja selle analoogide uudne asümmeetriline sünteesimine |
JP2000509049A (ja) * | 1996-04-26 | 2000-07-18 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | アテローム性動脈硬化症の治療用アゼチジノン誘導体 |
US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
US6593078B1 (en) | 1999-04-16 | 2003-07-15 | Schering Corporation | Use of azetidinone compounds |
NZ527852A (en) | 2001-03-28 | 2005-03-24 | Schering Corp | Enantioselective synthesis of azetidinone intermediate compounds |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
ES2311806T3 (es) | 2003-03-07 | 2009-02-16 | Schering Corporation | Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
US4777252A (en) * | 1987-08-13 | 1988-10-11 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
NZ228600A (en) * | 1988-04-11 | 1992-02-25 | Merck & Co Inc | 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives |
WO1993000332A1 (en) * | 1991-06-25 | 1993-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
-
1991
- 1991-10-07 IL IL99658A patent/IL99658A0/xx unknown
- 1991-10-08 CA CA002052973A patent/CA2052973A1/en not_active Abandoned
- 1991-10-09 EP EP91309293A patent/EP0481671A1/en not_active Withdrawn
- 1991-10-14 FI FI914833A patent/FI914833A/fi unknown
- 1991-10-14 MX MX919101574A patent/MX9101574A/es unknown
- 1991-10-14 PT PT99226A patent/PT99226A/pt not_active Application Discontinuation
- 1991-10-14 AU AU85833/91A patent/AU648345B2/en not_active Ceased
- 1991-10-14 NO NO91914027A patent/NO914027L/no unknown
- 1991-10-15 JP JP3331128A patent/JPH05132458A/ja active Pending
- 1991-10-16 IE IE361291A patent/IE913612A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH05132458A (ja) | 1993-05-28 |
NO914027L (no) | 1992-04-21 |
EP0481671A1 (en) | 1992-04-22 |
IE913612A1 (en) | 1992-04-22 |
AU648345B2 (en) | 1994-04-21 |
FI914833A (fi) | 1992-04-16 |
AU8583391A (en) | 1991-12-19 |
CA2052973A1 (en) | 1992-04-16 |
PT99226A (pt) | 1992-09-30 |
IL99658A0 (en) | 1992-08-18 |
NO914027D0 (no) | 1991-10-14 |
FI914833A0 (fi) | 1991-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9101574A (es) | Nuevas azetidinonas substituidas como agentes anti-inflamatorios y antidegenerativos | |
FI931357A0 (fi) | Framstaellning av polyhydroxifettsyraamider i naervaro av loesningsmedel | |
DE69323889T2 (de) | Schmelzgeblasener vliesstoff | |
NO307250B1 (no) | Brokran | |
FI923779A (fi) | Foerbaettringar i tillverkningen av nylongarn | |
MX9205938A (es) | Compuestos de di-ter-butilfenol utiles como agentes antiinflamatorios | |
DE69301972D1 (de) | Unterhose | |
MX9100508A (es) | Composicion fotoresistente electrodepositable fotoreproducible | |
FI953078A0 (fi) | Suodatinsavuke | |
FI925724A0 (fi) | Producering av immunoglobuliner i trichoderma | |
TR25296A (tr) | Fungusid aktivitesine sahip bilesik kombinasyonlari | |
FI88609B (fi) | Kompostor | |
FI923862A (fi) | Anordning foer reducerad effektmatning | |
TR25733A (tr) | Fungusid aktivitesine sahip bilesik kombinasyonlari | |
KR920009092U (ko) | 드로우어웨이팁 | |
DE69030587D1 (de) | Falle | |
FIU920149U0 (fi) | Kompostor | |
MD308B1 (ro) | Electrostimulator | |
FI925908A (fi) | Antivirala medel innehaollande heteropolyvolframat | |
FI924296A (fi) | Rengoeringsprodukter i vaetskeform | |
DK256090D0 (da) | Snitteaggregat | |
KR910016161U (ko) | 신축식 원간구조 | |
FI930123A (fi) | Foerfarande foer anvaendning av oxiderade lipoproteiner i virusartade infektioner | |
FI88480C (fi) | Lastningsbrygga | |
ZA918163B (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents |